Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.8.0 instead of v3.7.2; the displayed page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T12:29:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A notice appears above the ClinicalTrials.gov error page announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T12:20:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.1 to v3.7.2 while the study record continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T12:52:01.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:31:48.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A 403 Forbidden error now displays on the study page, replacing the former content with an error screen. This blocks access to the study details and related information.
    Difference
    18%
    Check dated 2026-09-21T22:25:51.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The site revision indicator was updated from Revision: v3.6.5 to Revision: v3.6.6, signaling a deployment or update to the page. This change does not alter the study content or how the page presents information to users.
    Difference
    0.1%
    Check dated 2026-08-31T17:50:52.000Z thumbnail image

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.